Fluoxetine and trifluoperazine in human brain: A 19F-nuclear magnetic resonance spectroscopy study
- 31 August 1992
- journal article
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 45 (2) , 95-104
- https://doi.org/10.1016/0925-4927(92)90003-m
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopyBiological Psychiatry, 1991
- Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopyPsychiatry Research: Neuroimaging, 1990
- NMR spectroscopy detects brain trifluoperazine and fluoxetine : Craig N. Karson, M.D., Joseph Newton, M.D., Richard Komoroski, Ph.D. University of Arkansas for the Medical Sciences and the John L. McClellan Veterans Affairs Hospital, Little Rock, AR 72215Biological Psychiatry, 1990
- Plasma-Level Response Relationships with Fluoxetine and ZimelidineClinical Neuropharmacology, 1990
- FluoxetineDrugs, 1986
- Fluorinated psychopharmacological agents: Noninvasive observation by flourine-19 nuclear magnetic resonancePsychiatry Research, 1986
- Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effectsPsychopharmacology, 1981
- Fluphenazine pharmacokinetics and therapeutic responsePsychopharmacology, 1981